Clinical Trials Browser

Active not recruiting × elotuzumab × 90 days × Clear all

NCT02718833 2026-01-22

A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma

Phase 2 Active not recruiting

Multiple Myeloma, Recurrence

NCT04517851 2026-01-13

Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis

Phase 2 Active not recruiting

Polycythemia Vera, Primary Myelofibrosis

NCT05560399 2026-01-02

CC-220

Phase EARLY_PHASE1 Active not recruiting

Multiple Myeloma